IONQ · IonQ, Inc. · Stock research

Current Thesis

The binary lands tonight. Q2 2026 results are due after the 2026-08-05 close with a 4:30pm ET call, and the tape has run into it hard: $31.99 on 07-29, then $35.77 (+11.82%), $36.44, $38.85 (+6.61%) and $41.72 on 08-04 (+7.39%) — four consecutive up sessions, +30.4% off the capitulation close. Options were priced for a 19.55% move as of 07-30, roughly double the 9.86% average absolute post-earnings move of the prior four quarters.

The quarter being reported ended 2026-06-30, one month before the $1.8B SkyWater acquisition closed on 07-31. Tonight's revenue line is therefore still quantum-only, guided $65–68M against $66.58M consensus and a $0.54 loss per share. The number that grades the new company is the FY2026 outlook. That $260–270M range was set on a quantum-only basis; SkyWater booked $160.7M of revenue in its own quarter ended 2026-03-29. From Q3 the foundry is the larger half of the top line, and the guide as published stops being a like-for-like measure.

The leg that carried this name through spring still has no dollar sign on it. IonQ was selected into the Missile Defense Agency's SHIELD IDIQ pool on 2026-02-23 — a vehicle with a $151B ceiling shared across more than 2,400 awardees. Five-plus months later no named, dollar-denominated task order has been announced. The two most recent headlines extend that shape: the 08-03 EPB commitment is $15M flowing out of IonQ over five years to fund a Chattanooga research center, and the 08-04 Sandia National Laboratories MoU is explicitly non-binding with no contract value attached.

So the four-session advance was sourced externally — a Wedbush initiation on 08-03, a competitor's AT&T contract on 07-27, sector beta — and it arrived below both major moving averages. The 08-04 close of $41.72 sits under the 200-day at $43.50 and well under the 50-day at $50.07.

Bullish and bearish views on IonQ, Inc.

The model's bull view on IonQ, Inc. (IONQ), in brief: 2026-05-06: Q1 revenue $64.67M, +755% YoY, against $49.79M consensus. The bear view: 2026-02-23 → 2026-08-05: SHIELD is eligibility to bid, shared across 2,400-plus awardees. Both cases follow in full.

Bull Case

• 2026-05-06: Q1 revenue $64.67M, +755% YoY, against $49.79M consensus. Backlog $470M, +550% YoY. FY2026 guide raised to $260–270M with Q2 guided $65–68M. The sub-scale-revenue objection was answered on the top line before SkyWater was added.
• 2026-05-08 (SkyWater 10-Q, quarter ended 2026-03-29): the acquired asset posted $160.7M revenue, +162% YoY, with $32.2M gross profit (20% margin) and Adjusted EBITDA of $13.0M. The Fab 25 segment alone did $86.3M revenue, $19.1M gross profit and $11.9M net income. Positive segment-level net income from anything inside this perimeter is new.
• 2026-08-03: Wedbush assumed coverage at Outperform, $75 target, built on a 10-year DCF at a 22% WACC and 5% terminal growth, naming SkyWater consolidation as the most likely near-term source of estimate revisions. The stock closed +6.61% that session.
• 2026-08-04: Consensus 12-month target $70.71 across 14 ratings (1 Strong Buy, 8 Buy, 4 Hold, 1 Sell); a separate 12-analyst panel averages $69.11 with a $44.78 low. Every published target sits above the $41.72 close.
• 2026-08-04: The Sandia MoU covers system optimization, device development, characterization and testing at the Quantum Demonstration Facility in New Mexico. Sandia fabricated ion traps for IonQ's earliest systems, so the counterparty is a supply-chain incumbent rather than a new logo.
• 2026-07-31: The realized merger consideration was $15.00 cash plus 0.4883 IonQ shares per SkyWater share. The S-4 collar caps at 0.5265 (20-day VWAP ≤$37.99) and floors at 0.3326 (≥$60.13), so the stock leg settled inside the band and away from the share-heavy cap.
• 2026-03-31 (Q1 10-Q): Cash and investments $3.1B — $493.5M cash and equivalents, $1.54B short-term, $1.06B long-term. The cash half of SkyWater was funded with no announced raise, and no ATM has been disclosed through 2026-08-04.

Bear Case

• 2026-02-23 → 2026-08-05: SHIELD is eligibility to bid, shared across 2,400-plus awardees. Five-plus months on, no task order carrying a stated dollar figure.
• 2026-08-04: Three company announcements in five sessions, none carrying inbound revenue. The Sandia MoU has no dollar value; the EPB item is a $15M outflow; the Wedbush note is a valuation opinion.
• 2026-08-04: The +7.39% session — the largest of the run — traded 24.9M shares against a 25.5M average. The advance into the print did not bring incremental volume with it.
• 2026-05-08: SkyWater's legacy segment posted $74.4M revenue and a $23.1M net loss in the March quarter. The profitable half is Fab 25, acquired 2025-06-30, and $10.2M of its $86.3M revenue was non-cash from a long-term supply agreement.
• 2026-05-08: SkyWater carried $22.2M cash against $182.4M drawn on its revolver with $61.8M of remaining availability. Drawn revolver debt now sits inside the consolidated balance sheet.
• 2026-07-31: The completion 8-K was filed under Items 8.01 and 9.01. Neither an aggregate issued-share count nor audited acquired-company financials had been filed as of 2026-08-05. Quoted market cap of $15.57B on 08-04 implies 373.27M shares — the pre-close count ($41.72 × 373.27M = $15.57B, an arithmetic inference, not a company disclosure) — so screened market cap understates the post-deal figure.
• Robert Cardillo 3,773 at $49.90. Insiders disposed of 13,102 shares valued at $701,489 over the trailing 90 days, all at prices above the 08-04 close.
• 2026-07-23: Jim Cramer warned against owning IonQ on air, framing it as hard to hold into rising rates — mainstream negative coverage on a name already 50.7% below its $84.64 52-week high.

Setup & Price Structure

The structure is a sharp bounce inside a broken trend, not a base. The 52-week range is $25.89–$84.64. The 07-29 close of $31.99 capped a run of weekly declines; the week ended 07-31 closed $36.44, holding the $36 shelf by 44 cents. Four sessions later price is $41.72, still 4.1% under the 200-day ($43.50) and 16.7% under the 50-day ($50.07), both as of 2026-08-04.

Crowding evidence is legible and one-directional. 12.67% of float, 2.8 days to cover, up 6.84% from 44,033,601 at 06-30 and down from 57,963,134 at 05-29. Institutional ownership is 41.42%, leaving most of the register outside 13F reporting. Beta is 3.28. A dedicated inverse ETF complex (IONZ, QBTZ, RGTZ) posted gains up to 108% during the 2026-07-17 quantum drawdown, so there is a listed, liquid vehicle for the short side of this cohort.

The gap-risk arithmetic is straightforward: a 19.55% priced move from $41.72 spans roughly $33.6 to $49.9. The lower half of that range erases the entire four-session advance and puts price back at the weekly shelf; the upper half runs into the 50-day. Where the reaction settles relative to $36 and $43.50 is the observable that matters.

Catalyst Calendar (next 30 days)

• ~2026-08-11 (est.) — NYSE semi-monthly short-interest publication covering the 2026-07-31 settlement. First read on whether the 12.67%-of-float short base covered into the 07-29 capitulation or was added into the bounce.
• ~2026-08 to 2026-09 (est.) — Pending Item 2.01 8-K amendment carrying SkyWater's audited acquired-company financial statements. Sets the baseline for consolidated gross margin.
• 2026-09-08 — Investor day for the combined company (just outside the 30-day window). First full articulation of the quantum-plus-foundry model, including whether the two are reported as separate segments and whether SHIELD has converted to a funded task order.

Elapsed catalysts

• 2026-08-05 — Q2 2026 results after market close, conference call 4:30pm ET. Revenue is quantum-only against a $65–68M guide and $66.58M consensus. The FY2026 outlook is the first place SkyWater can appear, and the call is the first chance to split funded from booked government revenue. (passed 4d ago)
• 2026-08-05 (or shortly after) — Q2 10-Q. The cover-page share count is dated after the 07-31 close, making it the first observable measure of actual SkyWater dilution against 373.27M shares outstanding at a realized 0.4883 exchange ratio. (passed 4d ago)
• 2026-08-06 — D-Wave (QBTS) and Rigetti (RGTI) Q2 results. QBTS revenue is estimated at $4.02M, +30% YoY, on a $0.09 loss; RGTI at a $0.03 loss. Options priced moves above 13% on both. Cohort repricing runs a second consecutive session. (passed 3d ago)

What Would Change Our Mind

The bounce has one structural job: defend the $36 weekly shelf the 07-31 close held by 44 cents. A daily close below $36 erases the four-session advance off the 2026-07-29 close of $31.99 and re-opens the $30 area, with the secondary condition being a Q2 print showing revenue under the $65M guide low or an FY2026 cut from $260–270M.

The case turns more constructive on three specific observables, none of which exists yet: a named SHIELD or Golden Dome task order with a stated dollar value; an FY2026 guide raised with quantum and foundry broken out as separate reported segments, so the $260–270M base stays measurable; and a reclaim of the 200-day at $43.50 followed by the 50-day at $50.07 on above-average volume rather than on cohort beta.

The case degrades further if the 08-05 release reports consolidated revenue on a single line with no segment split and management declines to quantify funded government revenue on the call — that would convert the disputed funded-versus-booked question from unresolved into unauditable. Backlog printing above $470M while quarterly revenue lands at or below $65M would carry the same signature.

Correlation Notes

This name trades as cohort beta first and company news second. On 2026-07-27 it rose 9.38% on D-Wave's AT&T contract — a competitor's announcement. On 2026-07-13 it fell alongside bitcoin and crypto equities as US–Iran tensions drained risk appetite, with no IonQ-specific news. Beta 3.28 and average volume of 25.4M shares mean macro risk-off sessions move it more than product milestones do.

The 08-06 QBTS and RGTI prints land the session after IonQ's, so quantum-sector positioning gets marked twice in 24 hours; a weak IonQ reaction and weak peer prints compound rather than offset. Cramer's 07-23 framing — hard to own when rates rise — describes the long-duration behavior the cohort has shown all year.

One correlation is newly loosening. From Q3 2026 the consolidated business carries a US semiconductor foundry with $442.14M of FY2025 revenue and eight commercial quantum ATS engagements. Whether the equity starts tracking semi-cap and foundry comparables instead of the pure-play quantum complex is testable at the 09-08 investor day and in the first consolidated quarter.